A carregar...
Predictors of Successful Cardioversion with Vernakalant in Patients with Recent‐Onset Atrial Fibrillation
BACKGROUND: Vernakalant is a novel atrial‐selective antiarrhythmic drug able to convert recent‐onset atrial fibrillation (AF) with reportedly low proarrhythmic risk. Successful cardioversion predictors are largely unknown. We sought to evaluate clinical and electrocardiographic predictors of cardiov...
Na minha lista:
| Publicado no: | Ann Noninvasive Electrocardiol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931769/ https://ncbi.nlm.nih.gov/pubmed/25040826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12178 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|